Androgen Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

Expert Insights from the Leading Minds in Oncology

Friday, May 11, 2018 | 2 PM EDT
  • Review the cardioprotective role of androgens
  • Hear expert perspectives on metabolic changes associated with ADT
  • Submit questions and uncover information regarding ADT and cardiovascular risk
  • Uncover a management algorithm for patients on ADT


Presenters

Dipti Gupta, MD, MPH
Memorial Sloan Kettering Cancer Center
New York, New York
Susan F. Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, New York


Register

* Required Fields
x